Latest Pancreatic Cancer Articles

Image representing Celgene as depicted in Crun...

Image via CrunchBase

During the recent ASCO GI conference, the big news was the release of the results of the Abraxane trials.  The data show that the lives of pancreatic cancer patients can be extended by two months when adding Abraxane into the standard gemcitabine treatment regimen.

Sally Church at the PharmaStrategy blog gave a good overview of the conference, and included an interview with Dr. Hedy Lee Kindler who gave us the clinicians perspective on the Abraxane results.

In addition to this Congress signed off on the Recalcitrant Cancer Research Act which provides funding for traditionally under funded diseases like Pancreatic Cancer.

News

Articles

Here are the latest additions to the Mendeley Pancreatic Cancer Genomics collection.

About aspenbio

I write software for scientists. I'm interested in Java/Groovy/Grails, the Semantic Web and Cancer Biology.
This entry was posted in Drug Development, pancreatic cancer and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s